An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.

Biol Direct · 2022 · PMC9082922 · PMID 35534873

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Differences in the expression of HLA genes did not reach statistical significance, while CD96 appears even more differentially expressed in this subgroup than in HM tumors, comparing with non-HM subset.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.